GO:0001523 retinoid metabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001523 (retinoid metabolic process) describes all chemical reactions and pathways involving retinoids, isoprenoid compounds derived from four prenyl groups linked head-to-tail, including retinol, retinal, retinoic acid and synthetic analogs.
• Retinoid metabolism is essential for vision, embryonic development, immune regulation, skin homeostasis and cancer suppression, and its dysregulation is linked to squamous cell carcinoma, ferroptosis resistance and developmental disorders.
• Key enzymes include retinol saturase (RETSAT), alcohol dehydrogenases (ADH), aldehyde dehydrogenases (ALDH1A1/2/3), and cytochrome P450 family members (CYP26A1/B1/C1), while binding proteins such as CRBP1/2 and CRABP1/2 control intracellular transport and availability.
• Retinoid metabolism intersects with cell death pathways: RETSAT-mediated retinoid metabolism can impair ferroptosis defense in cancer cells, making it a potential therapeutic target.
• Cutaneous squamous cell carcinoma and other skin cancers show altered retinoid metabolism, and topical retinoids are used clinically, with absorption influenced by vehicle, light and dose.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models enable causal dissection of retinoid metabolic genes in cancer, differentiation and immune contexts.
Description
Retinoid metabolic process (GO:0001523) encompasses the chemical reactions and pathways involving retinoids, a class of isoprenoids containing or derived from four prenyl groups linked head-to-tail. These molecules include retinol, retinal, retinoic acid and structurally similar natural or synthetic compounds, and they do not necessarily require vitamin A activity. Retinoids are critical for vision, embryonic patterning, immune function and epithelial differentiation, and their metabolism is tightly regulated by enzymes and binding proteins. Dysregulation of retinoid metabolism has been implicated in cancer, skin disorders and developmental abnormalities, making this GO term a focal point for biomedical research. Understanding the molecular players and regulatory logic of retinoid metabolic process is essential for developing targeted therapies and for interpreting genomic and proteomic data in relevant disease models.
retinoid metabolic process At A Glance
| GO ID | GO:0001523 |
|---|---|
| GO term | retinoid metabolic process |
| Ontology | biological_process |
| Synonym | retinoid metabolism |
| Major function | Enzymatic conversion, transport and degradation of retinoids such as retinol, retinal and retinoic acid |
| Key enzymes | RETSAT, ADH, ALDH1A1/2/3, CYP26A1/B1/C1 |
| Key binding proteins | CRBP1/2, CRABP1/2, RBP4 |
| Associated diseases | Cutaneous squamous cell carcinoma, ferroptosis resistance in cancer, developmental disorders |
| Research methods | CRISPR knockout/knock-in, RNA-seq, proteomics, lipidomics, imaging |
What Is GO:0001523?
GO:0001523 retinoid metabolic process is defined as the chemical reactions and pathways involving retinoids, any member of a class of isoprenoids that contain or are derived from four prenyl groups linked head-to-tail. Retinoids include retinol and retinal and structurally similar natural derivatives or synthetic compounds, but need not have vitamin A activity. In practice, this term covers the enzymatic conversion, transport, and degradation of retinoid molecules within cells and tissues.
Why Is retinoid metabolic process Important in Cell Biology?
Retinoid metabolic process is fundamental to human physiology because retinoids act as signaling molecules, visual chromophores and regulators of gene expression. Perturbations in this pathway contribute to cancer progression, skin pathology and immune dysfunction, and the pathway is a target for both natural and synthetic therapeutic retinoids. Studying GO:0001523 helps researchers connect molecular mechanisms to disease phenotypes and to identify actionable targets.
• Retinoids are essential for vision, embryonic development and immune regulation.
• Altered retinoid metabolism is observed in cutaneous squamous cell carcinoma and other cancers.
• RETSAT-mediated retinoid metabolism can impair ferroptosis defense, linking retinoid metabolism to cell death pathways.
• Retinoid binding proteins such as CRBP and CRABP regulate intracellular availability and signaling.
• Topical retinoid absorption is influenced by vehicle, light exposure and dose, affecting therapeutic efficacy.
• Retinoid metabolism intersects with vitamin D3 and thymic stromal lymphopoietin signaling in keratinocytes.
• Nur77 translocation is targeted by retinoid-related molecules, connecting retinoid metabolism to apoptosis regulation.
• Dead cell clearance by stem cells is tightly regulated and may intersect with retinoid-dependent tissue fitness.
• Retinoid metabolic genes are candidate biomarkers and therapeutic targets in oncology.
• CRISPR models enable functional validation of retinoid metabolic genes in disease contexts.
What Happens During retinoid metabolic process?
Uptake and intracellular transport of retinoids
In simple terms: Retinoids enter cells and are carried by binding proteins to the right places.
Retinoids such as retinol are taken up by cells and bound to intracellular binding proteins including CRBP1 and CRBP2, which facilitate their solubilization and presentation to enzymes. Retinol can also be esterified for storage or oxidized to retinal and retinoic acid. The availability of free retinol is tightly controlled by these binding proteins, influencing downstream signaling.
Enzymatic conversion of retinol to retinal and retinoic acid
In simple terms: Enzymes convert retinol step by step into active forms like retinoic acid.
Alcohol dehydrogenases (ADH) and short-chain dehydrogenases/reductases catalyze the reversible oxidation of retinol to retinal, which is then irreversibly oxidized to retinoic acid by aldehyde dehydrogenases such as ALDH1A1, ALDH1A2 and ALDH1A3. These reactions are central to generating retinoic acid, the major active retinoid for gene regulation.
Retinoic acid signaling and catabolism
In simple terms: Retinoic acid sends signals and is then broken down to stop the signal.
Retinoic acid binds nuclear receptors (RARs and RXRs) to regulate transcription, and its levels are controlled by cytochrome P450 enzymes such as CYP26A1, CYP26B1 and CYP26C1 that catalyze its oxidation to inactive metabolites. This catabolic step is critical for preventing excessive retinoid signaling.
Retinol saturase and alternative retinoid pathways
In simple terms: Other enzymes like RETSAT modify retinoids and affect cell death defenses.
Retinol saturase (RETSAT) catalyzes the saturation of retinol to dihydroretinol and has been shown to mediate retinoid metabolism that impairs ferroptosis defense in cancer cells. This highlights additional enzymatic routes within GO:0001523 that influence cell survival and redox balance.
Retinoid metabolism in skin and immune regulation
In simple terms: Retinoids affect skin cells and immune signals.
In keratinocytes, retinoid metabolism intersects with vitamin D3 and thymic stromal lymphopoietin signaling, influencing atopic dermatitis-like responses. Topical retinoid absorption in skin depends on vehicle, light exposure and dose, which affects local retinoid availability and therapeutic outcomes. These findings link retinoid metabolic process to cutaneous biology and immune regulation.
Key Genes Involved in GO:0001523 retinoid metabolic process
The following genes and proteins are central to retinoid metabolic process (GO:0001523) based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RETSAT | Catalyzes saturation of retinol to dihydroretinol | Linked to ferroptosis defense in cancer |
| ALDH1A1 | Oxidizes retinal to retinoic acid | Key enzyme in retinoic acid synthesis |
| ALDH1A2 | Oxidizes retinal to retinoic acid | Embryonic development and differentiation |
| ALDH1A3 | Oxidizes retinal to retinoic acid | Cancer stem cell and differentiation studies |
| ADH1 | Reversible oxidation of retinol to retinal | Retinol homeostasis |
| CYP26A1 | Catabolizes retinoic acid | Prevents excessive retinoid signaling |
| CYP26B1 | Catabolizes retinoic acid | Developmental patterning |
| CYP26C1 | Catabolizes retinoic acid | Retinoid gradient control |
| CRBP1 | Intracellular retinol binding | Regulates retinol availability |
| CRBP2 | Intracellular retinol binding | Retinol transport in enterocytes |
| CRABP1 | Intracellular retinoic acid binding | Modulates retinoic acid signaling |
| CRABP2 | Intracellular retinoic acid binding | Delivers retinoic acid to nuclear receptors |
| RBP4 | Extracellular retinol transport | Systemic retinoid distribution |
| RARα | Nuclear receptor for retinoic acid | Transcriptional regulation |
| RXRα | Nuclear receptor partner | Retinoid signaling |
| Nur77 | Orphan nuclear receptor targeted by retinoids | Apoptosis regulation |
| TSLP | Cytokine induced by vitamin D3 and retinoid-related signals | Skin inflammation |
How Is retinoid metabolic process Regulated?
Retinoid metabolic process is regulated at multiple levels, including substrate availability, enzyme expression and feedback control. Intracellular binding proteins such as CRBP and CRABP modulate the access of retinoids to enzymes and receptors. Retinoic acid levels are controlled by the balance between synthesis (ALDH1A enzymes) and catabolism (CYP26 enzymes), which prevents toxic accumulation and maintains signaling gradients. In cancer cells, RETSAT-mediated retinoid metabolism can impair ferroptosis defense, indicating that metabolic flux through this pathway is linked to redox regulation. Additionally, topical application and light exposure influence retinoid stability and absorption in skin.
retinoid metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RETSAT | Ferroptosis resistance in cancer | Knockout and overexpression in cancer cell lines |
| ALDH1A1 | Cancer differentiation and stemness | CRISPR knockout in tumor models |
| CYP26A1 | Retinoic acid catabolism and developmental disorders | Point mutation and knock-in models |
| CRABP2 | Retinoic acid signaling in cancer | Overexpression and knockout studies |
| Nur77 | Apoptosis regulation | Knockout and translocation assays |
Retinoid metabolism in cutaneous squamous cell carcinoma
Cutaneous squamous cell carcinoma is associated with altered retinoid metabolism, and retinoids have been studied as preventive and therapeutic agents. Changes in retinoid-metabolizing enzymes can affect differentiation and proliferation in skin tumors.
RETSAT and ferroptosis resistance in cancer
RETSAT-mediated retinoid metabolism impairs a ferroptosis defense system in cancer cells, linking retinoid metabolism to cell death evasion. This suggests that targeting RETSAT or related pathways could sensitize tumors to ferroptosis inducers.
Retinoid metabolism and skin inflammation
Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes, triggering atopic dermatitis-like responses, which intersects with retinoid signaling in skin. Retinoid absorption and stability in skin are influenced by vehicle, light and dose, affecting therapeutic use.
Retinoid-related molecules and apoptosis
Retinoid-related molecules can target Nur77 translocation, which regulates apoptosis, connecting retinoid metabolism to cell death control. This pathway is relevant for cancer therapy development.
From retinoid metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does RETSAT loss alter ferroptosis sensitivity? | CRISPR knockout in cancer cell lines |
| How does ALDH1A2 point mutation affect retinoic acid synthesis? | Point-mutation knock-in in cell models |
| Can CRABP2 overexpression enhance retinoic acid signaling? | Overexpression cell model |
| What is the effect of CYP26A1 knockout on retinoid gradients? | Knockout in differentiation models |
| Does tagged RBP4 knock-in reveal transport dynamics? | Tagged knock-in in hepatocytes |
| How does Nur77 translocation respond to retinoids? | Knockout and imaging models |
How to Study the retinoid metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Retinoid metabolic gene profiling |
| CRISPR screening | Gene essentiality and pathway dependencies | Identifying regulators of retinoid metabolism |
| Proteomics | Protein abundance and modifications | Enzyme expression in cancer models |
| Lipidomics | Retinoid species levels | Pathway activity measurement |
| Imaging | Nur77 translocation and signaling | Apoptosis regulation studies |
| Percutaneous absorption assay | Skin penetration of retinoids | Topical formulation testing |
| Flow cytometry | Cell differentiation and death | Retinoid effects on immune and cancer cells |
Genomic and transcriptomic profiling
RNA-seq and CRISPR screening can identify genes and pathways that regulate retinoid metabolic process, including enzymes and binding proteins. These methods help link genotype to retinoid-related phenotypes in cancer and differentiation models.
Proteomic and lipidomic analysis
Proteomics and lipidomics can quantify retinoid-metabolizing enzymes and retinoid species, providing a direct readout of pathway activity. Such approaches are useful for validating CRISPR perturbations.
Imaging and translocation assays
Imaging-based assays can monitor Nur77 translocation and retinoid-dependent signaling in live cells. These methods complement biochemical measurements of retinoid metabolism.
Skin absorption and topical studies
Percutaneous absorption studies assess how vehicle, light exposure and dose affect retinoid delivery in skin, which is critical for topical therapeutic development. These methods are relevant for cutaneous squamous cell carcinoma and inflammatory skin diseases.
How CRISPR Can Be Used to Study GO:0001523 retinoid metabolic process
Knockout
CRISPR knockout of retinoid metabolic genes such as RETSAT, ALDH1A1 or CYP26A1 enables loss-of-function studies to determine their role in retinoic acid synthesis, catabolism and ferroptosis defense. Knockout models are essential for causal inference in cancer and differentiation research.
Point Mutation
Point-mutation knock-in can model specific amino acid changes in enzymes like ALDH1A2 or RETSAT to dissect catalytic activity and substrate specificity. These models help link genetic variants to altered retinoid metabolism.
Knock-in
Knock-in of tags or reporters into endogenous loci such as CRBP1 or RBP4 allows real-time tracking of retinoid binding and transport. Tagged knock-in models are valuable for imaging and proteomic studies.
Overexpression
Overexpression of retinoid metabolic genes, such as CRABP2 or RETSAT, can amplify pathway activity and reveal gain-of-function phenotypes in cancer and immune cells. These models complement knockout approaches for bidirectional pathway control.
How EDITGENE Supports retinoid metabolic process Research
Researchers studying retinoid metabolic process-related genes often need to determine whether a candidate gene is causally involved in retinoid synthesis, transport or degradation, and how its perturbation affects disease phenotypes. EDITGENE provides CRISPR-based cell model services to enable such functional studies with high specificity and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for retinoid metabolic process research.
Frequently Asked Questions About retinoid metabolic process
What is GO:0001523 retinoid metabolic process?
GO:0001523 is a Gene Ontology biological process term describing the chemical reactions and pathways involving retinoids, including retinol, retinal and retinoic acid, as defined by QuickGO.
What genes are involved in retinoid metabolic process?
Key genes include RETSAT, ALDH1A1/2/3, ADH1, CYP26A1/B1/C1, CRBP1/2, CRABP1/2 and RBP4.
Why is retinoid metabolism important in cancer?
Altered retinoid metabolism is linked to cancer progression, including cutaneous squamous cell carcinoma and ferroptosis resistance mediated by RETSAT.
How does RETSAT affect ferroptosis?
RETSAT-mediated retinoid metabolism impairs a ferroptosis defense system in cancer cells, making it a potential therapeutic target.
What is the role of retinoic acid in gene regulation?
Retinoic acid binds nuclear receptors RAR and RXR to regulate transcription, and its levels are controlled by synthesis and CYP26-mediated catabolism.
How is retinoid metabolism studied experimentally?
Common methods include CRISPR knockout, RNA-seq, proteomics, lipidomics and imaging, as well as percutaneous absorption assays for topical retinoids.
What diseases are associated with retinoid metabolic process?
Diseases include cutaneous squamous cell carcinoma, skin inflammation and developmental disorders linked to retinoic acid signaling.
Can CRISPR be used to study retinoid metabolic genes?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models enable functional dissection of retinoid metabolic genes.
What is the difference between retinol and retinoic acid?
Retinol is an alcohol form of vitamin A that can be oxidized to retinal and then to retinoic acid, the major active retinoid for gene regulation.
How do binding proteins regulate retinoid metabolism?
CRBP and CRABP bind retinol and retinoic acid intracellularly, controlling their availability to enzymes and nuclear receptors.
Conclusion
GO:0001523 retinoid metabolic process is a central biological pathway governing the synthesis, transport and degradation of retinoids, with critical roles in vision, development, immunity and cancer. Dysregulation of this pathway contributes to diseases such as cutaneous squamous cell carcinoma and ferroptosis resistance, making it a rich area for therapeutic targeting. CRISPR-based models and multi-omics approaches provide powerful tools to dissect the molecular players and regulatory logic of retinoid metabolism.
References
- 1. Stewart KS et al.. 2024. Stem cells tightly regulate dead cell clearance to maintain tissue fitness.. Nature 633(8029):407-416 PMID: 39169186
- 2. Lehman PA et al.. 1988. Percutaneous absorption of retinoids: influence of vehicle, light exposure, and dose.. J Invest Dermatol 91(1):56-61 PMID: 3385216
- 3. Li M et al.. 2006. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis.. Proc Natl Acad Sci U S A 103(31):11736-41 PMID: 16880407
- 4. Zhang XK. 2007. Targeting Nur77 translocation.. Expert Opin Ther Targets 11(1):69-79 PMID: 17150035
- 5. Bi G et al.. 2023. Retinol Saturase Mediates Retinoid Metabolism to Impair a Ferroptosis Defense System in Cancer Cells.. Cancer Res 83(14):2387-2404 PMID: 37184371
- 6. Napoli JL. 2016. Functions of Intracellular Retinoid Binding-Proteins.. Subcell Biochem 81:21-76 PMID: 27830500
- 7. D'Ambrosio DN et al.. 2011. Vitamin A metabolism: an update.. Nutrients 3(1):63-103 PMID: 21350678
- 8. Everts HB et al.. 2021. Retinoids in Cutaneous Squamous Cell Carcinoma.. Nutrients 13(1) PMID: 33466372
